P1446: PHASE I STUDY DATA UPDATE OF PHE885, A FULLY HUMAN BCMA‐DIRECTED CAR‐T CELL THERAPY MANUFACTURED USING THE T‐CHARGETM PLATFORM FOR PATIENTS WITH RELAPSED/REFRACTORY (R/R) MULTIPLE MYELOMA (MM)

P1446: PHASE I STUDY DATA UPDATE OF PHE885, A FULLY HUMAN BCMA‐DIRECTED CAR‐T CELL THERAPY MANUFACTURED USING THE T‐CHARGETM PLATFORM FOR PATIENTS WITH RELAPSED/REFRACTORY (R/R) MULTIPLE MYELOMA (MM)

Saved in:
Bibliographic Details
Published in:HemaSphere Vol. 6; no. Suppl; pp. 1329 - 1330
Main Authors: Sperling, A. S., Nikiforow, S., Derman, B., Nadeem, O., Mo, C., Laubach, J., Anderson, K., Alonso, A., Im, S.‐Y., Ikwgawa, S., Prabhala, R., Hernandez Rodriduez, D., Daley, H., Shaw, K. L., Arihara, Y., Ansari, S., Quinn, D. S., Pearson, D., Hack, A., Treanor, L., Bu, D., Mataraza, J., Rispoli, L., Credi, M., Ritz, J., Jakubowiak, A., De Vita, S., Munshi, N.
Format: Journal Article
Language:English
Published: Philadelphia, PA Lippincott Williams & Wilkins 23-06-2022
Wiley
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:2572-9241
2572-9241
DOI:10.1097/01.HS9.0000848640.53562.8f